Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
hpn217 (1 trial)
hpn328 (1 trial)
hpn536 (1 trial)
hpn424 (1 trial)
Lung Neoplasms (Phase 2)
Multiple Myeloma (Phase 2)
Neoplasms (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Prostatic Neoplasms (Phase 1)
Small Cell Lung Carcinoma (Phase 2)
Trials (4 total)
Trial APIs (4 total)